US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Clearmind Medicine, Inc.

6.60

+0.760013.01%

Post-market: 6.920.3200+4.85%19:53 EDT

Volume:147.08K

Turnover:901.07K

Market Cap:3.35M

PE:-0.06

High:6.70

Open:5.75

Low:5.54

Close:5.84

52wk High:3,840.00

52wk Low:5.25

Shares:507.40K

Float Shares:507.20K

Volume Ratio:4.08

T/O Rate:29.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-118.4105

EPS(LYR):-2,427.8177

ROE:-106.98%

ROA:-53.08%

PB:0.26

PE(LYR):0.00

Loading ...

Overview Company News Filings

Clearmind doses 2 more patients in CMND-100 alcohol use disorder trial cohort 4

Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants NOW Treated in Ongoing Phase I/Iia Trial of Cmnd-100 for Alcohol Use Disorder

THOMSON REUTERS

Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder

Clearmind Medicine to host “Inside MEAI” webinar on CMND-100 trial data

Clearmind Medicine Announces “Inside Meai” Webinar Featuring New Insights From Cmnd-100 Psychedelic Clinical Trial

THOMSON REUTERS

BRIEF-Clearmind Medicine Announces Filing Of European Patent Application For Novel Psychedelic Compounds For The Treatment Of Ptsd

Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of Ptsd

THOMSON REUTERS

Clearmind names Hila Kiron-Revach board chair after Amitay Weiss steps down

Clearmind evaluates MEAI for FDA breakthrough therapy designation in alcohol use disorder trial

Clearmind Medicine Inc - Has Not Submitted or Received FDA Breakthrough Therapy Designation for Meai

THOMSON REUTERS

Clearmind Medicine issues $2.7 million convertible notes at 10% discount

Clearmind welcomes Trump executive order speeding FDA review of breakthrough psychedelic therapies

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM

Clearmind says CMND-100 meets primary safety endpoint in AUD Phase I/IIa trial

Clearmind Medicine Inc - Cmnd-100 Shows High Safety Profile at Highest Dosage With No Serious Adverse Events

THOMSON REUTERS

Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial

Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial

Clearmind announces DSMB recommendation to continue CMND-100 trial

Clearmind advances CMND-100 alcohol use disorder trial, raises dose to 160 mg

Clearmind Medicine Inc - Cmnd-100 Well Tolerated With No Serious Adverse Events in Third Cohort

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/CMND/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CMND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMND\",,,,,undefined,":{"symbol":"CMND","market":"US","secType":"STK","nameCN":"Clearmind Medicine, Inc.","latestPrice":6.6,"timestamp":1791403200000,"preClose":5.84,"halted":0,"volume":147082,"hourTrading":{"tag":"盘后","latestPrice":6.92,"preClose":6.6,"latestTime":"19:53 EDT","volume":3187,"amount":20860.9118,"timestamp":1791417200576,"change":0.32,"changeRate":0.048485,"amplitude":0.116667},"delay":0,"changeRate":0.13013698630136983,"floatShares":507200,"shares":507400,"eps":-118.410515,"marketStatus":"Not Yet Opened","change":0.76,"latestTime":"10-07 16:00:00 EDT","open":5.75,"high":6.7,"low":5.54,"amount":901073.1632239999,"amplitude":0.19863,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-118.410515,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791446400000},"marketStatusCode":0,"adr":0,"listingDate":1668142800000,"exchange":"NASDAQ","adjPreClose":5.84,"preHourTrading":{"tag":"盘前","latestPrice":5.73,"preClose":5.84,"latestTime":"09:29 EDT","volume":48258,"amount":290647.220724,"timestamp":1791379799036,"change":-0.11,"changeRate":-0.018836,"amplitude":0.410497},"postHourTrading":{"tag":"盘后","latestPrice":6.92,"preClose":6.6,"latestTime":"19:53 EDT","volume":3187,"amount":20860.9118,"timestamp":1791417200576,"change":0.32,"changeRate":0.048485,"amplitude":0.116667},"volumeRatio":4.081937},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMND\",,,,,undefined,":{"symbol":"CMND","floatShares":507200,"roa":"-53.08%","roe":"-106.98%","lyrEps":-2427.81768,"volumeRatio":4.081937,"shares":507400,"dividePrice":0,"high":6.7,"amplitude":0.19863,"preClose":5.84,"low":5.54,"week52Low":5.25,"pbRate":"0.26","week52High":3840.0002,"institutionHeld":0,"latestPrice":6.6,"eps":-118.410515,"divideRate":0,"volume":147082,"delay":0,"ttmEps":-118.410515,"open":5.75,"prevYearClose":144.8,"prevWeekClose":5.72,"prevMonthClose":6.4409,"prevQuarterClose":6.4409,"fiveDayClose":6.4409,"twentyDayClose":8.48,"sixtyDayClose":15.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CMND\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-10-05","symbol":"CMND","defaultRemindTime":1791207000000,"type":"split","dateTimestamp":1791172800000,"forFactor":8,"toFactor":1,"ratio":8},{"market":"US","date":"2026-05-21","symbol":"CMND","defaultRemindTime":1779370200000,"type":"split","dateTimestamp":1779336000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-12-15","symbol":"CMND","defaultRemindTime":1765809000000,"type":"split","dateTimestamp":1765774800000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2023-11-28","symbol":"CMND","defaultRemindTime":1701181800000,"type":"split","dateTimestamp":1701147600000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CMND\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CMND\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CMND\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CMND","date":"2026-10-06","current":-0.055738,"percent":0.92,"low":-18.473966,"twenty":-1.427176,"median":-0.823689,"eighty":-0.455615,"high":-0.132425,"avg":-2.100138,"sd":4.014022,"marketCap":2525298},"quantilePoints":[{"date":"2021-10-08","current":-18.012117,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23471549.77},{"date":"2021-10-15","current":-18.012117,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23660527.38},{"date":"2021-10-22","current":-17.781192,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23366442.66},{"date":"2021-10-29","current":-16.626569,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":21791515.03},{"date":"2021-11-05","current":-17.319343,"twenty":-61.834695,"median":-18.935815,"eighty":-5.327909,"marketCap":22614497.39},{"date":"2021-11-12","current":-16.16472,"twenty":-61.834695,"median":-18.473966,"eighty":-5.327909,"marketCap":20907283.62},{"date":"2021-11-19","current":-15.933796,"twenty":-61.834695,"median":-18.243042,"eighty":-5.327909,"marketCap":20493935.46},{"date":"2021-11-26","current":-17.319343,"twenty":-61.834695,"median":-18.243042,"eighty":-5.327909,"marketCap":22007930.87},{"date":"2021-12-03","current":-16.16472,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":20516830.56},{"date":"2021-12-10","current":-15.933796,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":20363701.64},{"date":"2021-12-17","current":-14.548248,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":18448575.82},{"date":"2021-12-23","current":-13.393625,"twenty":-61.834695,"median":-17.781192,"eighty":-5.327909,"marketCap":16986524.41},{"date":"2021-12-31","current":-13.393625,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":17198471.74},{"date":"2022-01-07","current":-12.700852,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":16298591.95},{"date":"2022-01-14","current":-12.239002,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":15851627.15},{"date":"2022-01-21","current":-10.853455,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":14077636.85},{"date":"2022-01-28","current":-12.931776,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":16468260.15},{"date":"2022-02-04","current":-14.548248,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18518085.11},{"date":"2022-02-11","current":-14.317323,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18343985.21},{"date":"2022-02-18","current":-14.317323,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18253458.39},{"date":"2022-02-25","current":-13.393625,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":17082383.51},{"date":"2022-03-04","current":-4.943147,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":14402278.55},{"date":"2022-03-11","current":-4.741385,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":13870054.34},{"date":"2022-03-18","current":-4.489184,"twenty":-61.834695,"median":-17.582743,"eighty":-5.327909,"marketCap":13226105.9},{"date":"2022-03-25","current":-2.663476,"twenty":-61.834695,"median":-17.550268,"eighty":-5.327909,"marketCap":12172123.95},{"date":"2022-04-01","current":-2.696359,"twenty":-61.834695,"median":-17.319343,"eighty":-5.327909,"marketCap":12315499.88},{"date":"2022-04-08","current":-3.090948,"twenty":-61.834695,"median":-17.319343,"eighty":-5.327909,"marketCap":14024131.41},{"date":"2022-04-14","current":-2.433299,"twenty":-61.834695,"median":-17.088418,"eighty":-5.327909,"marketCap":11016821.23},{"date":"2022-04-22","current":-2.30177,"twenty":-61.834695,"median":-16.857494,"eighty":-5.327909,"marketCap":10351738.45},{"date":"2022-04-29","current":-2.564829,"twenty":-61.834695,"median":-16.857494,"eighty":-5.327909,"marketCap":11431112.19},{"date":"2022-05-06","current":-2.531947,"twenty":-61.834695,"median":-16.511107,"eighty":-5.327909,"marketCap":11240443.79},{"date":"2022-05-13","current":-2.433299,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10747956.2},{"date":"2022-05-20","current":-2.466182,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10972362.04},{"date":"2022-05-27","current":-2.334652,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10462796.86},{"date":"2022-06-03","current":-2.400417,"twenty":-61.834695,"median":-15.933796,"eighty":-5.327909,"marketCap":10896966.45},{"date":"2022-06-10","current":-2.30177,"twenty":-61.834695,"median":-15.702871,"eighty":-5.327909,"marketCap":10273199.15},{"date":"2022-06-17","current":-2.400417,"twenty":-61.834695,"median":-15.471947,"eighty":-5.327909,"marketCap":10503138.41},{"date":"2022-06-24","current":-2.367534,"twenty":-61.744414,"median":-15.471947,"eighty":-5.327909,"marketCap":10469452.66},{"date":"2022-07-01","current":-1.560974,"twenty":-60.553176,"median":-15.147663,"eighty":-5.327909,"marketCap":10729626.02},{"date":"2022-07-08","current":-1.560974,"twenty":-57.232721,"median":-15.147663,"eighty":-5.327909,"marketCap":10710469.08},{"date":"2022-07-15","current":-1.605574,"twenty":-57.232721,"median":-15.147663,"eighty":-5.327909,"marketCap":10950633.46},{"date":"2022-07-22","current":-1.516375,"twenty":-57.130437,"median":-15.147663,"eighty":-5.327909,"marketCap":10468944.81},{"date":"2022-07-29","current":-1.427176,"twenty":-56.195971,"median":-15.147663,"eighty":-5.327909,"marketCap":9885259.74},{"date":"2022-08-05","current":-1.471776,"twenty":-55.226088,"median":-14.779173,"eighty":-5.327909,"marketCap":10092669.27},{"date":"2022-08-12","current":-1.427176,"twenty":-54.0772,"median":-14.548248,"eighty":-5.327909,"marketCap":9901792.86},{"date":"2022-08-19","current":-1.427176,"twenty":-43.677709,"median":-14.317323,"eighty":-5.327909,"marketCap":9745576.64},{"date":"2022-08-26","current":-1.382577,"twenty":-41.597849,"median":-14.317323,"eighty":-5.327909,"marketCap":9442770.76},{"date":"2022-09-02","current":-1.271079,"twenty":-41.597849,"median":-14.086399,"eighty":-5.327909,"marketCap":8615042.98},{"date":"2022-09-09","current":-1.427176,"twenty":-41.597849,"median":-14.086399,"eighty":-5.135307,"marketCap":9711214.67},{"date":"2022-09-16","current":-1.360278,"twenty":-41.597849,"median":-13.855475,"eighty":-5.135307,"marketCap":9096403.07},{"date":"2022-09-23","current":-1.248779,"twenty":-41.597849,"median":-13.62455,"eighty":-5.135307,"marketCap":8172150.47},{"date":"2022-09-30","current":-0.929266,"twenty":-41.597849,"median":-13.393625,"eighty":-5.135307,"marketCap":6512507.37},{"date":"2022-10-07","current":-1.087585,"twenty":-41.597849,"median":-13.393625,"eighty":-5.074202,"marketCap":7646662.48},{"date":"2022-10-14","current":-1.080702,"twenty":-41.597849,"median":-13.393625,"eighty":-5.074202,"marketCap":7496705.29},{"date":"2022-10-21","current":-1.049293,"twenty":-41.597849,"median":-13.278163,"eighty":-5.074202,"marketCap":7357917.44},{"date":"2022-10-28","current":-1.165881,"twenty":-41.597849,"median":-13.162701,"eighty":-5.074202,"marketCap":8234273.61},{"date":"2022-11-04","current":-1.08907,"twenty":-41.597849,"median":-13.162701,"eighty":-5.074202,"marketCap":7753472.39},{"date":"2022-11-11","current":-1.082212,"twenty":-38.270012,"median":-12.931776,"eighty":-5.074202,"marketCap":7833552.75},{"date":"2022-11-18","current":-1.935818,"twenty":-37.438053,"median":-12.700852,"eighty":-5.074202,"marketCap":13927482.09},{"date":"2022-11-25","current":-1.650458,"twenty":-37.438053,"median":-12.585389,"eighty":-5.074202,"marketCap":11873272.72},{"date":"2022-12-02","current":-1.27255,"twenty":-37.438053,"median":-12.008078,"eighty":-5.074202,"marketCap":9091614.07},{"date":"2022-12-09","current":-1.079739,"twenty":-37.438053,"median":-11.682462,"eighty":-4.943147,"marketCap":7625598.02},{"date":"2022-12-16","current":-1.40109,"twenty":-37.438053,"median":-11.587771,"eighty":-4.791826,"marketCap":9845331.19},{"date":"2022-12-23","current":-1.375382,"twenty":-37.438053,"median":-11.587771,"eighty":-4.741294,"marketCap":9740512.57},{"date":"2022-12-30","current":-1.141438,"twenty":-37.438053,"median":-11.587771,"eighty":-4.741294,"marketCap":8114893.38},{"date":"2023-01-06","current":-1.118301,"twenty":-37.438053,"median":-11.587771,"eighty":-4.539624,"marketCap":7989125.08},{"date":"2023-01-13","current":-1.62475,"twenty":-37.438053,"median":-11.587771,"eighty":-4.186477,"marketCap":11656520.47},{"date":"2023-01-20","current":-1.568192,"twenty":-37.438053,"median":-10.853455,"eighty":-4.136102,"marketCap":11253776.1},{"date":"2023-01-27","current":-1.33682,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9661985.46},{"date":"2023-02-03","current":-1.332642,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9371651.68},{"date":"2023-02-10","current":-1.393097,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9812413.93},{"date":"2023-02-17","current":-1.272187,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":8867258.2},{"date":"2023-02-24","current":-1.240431,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":8572078.87},{"date":"2023-03-03","current":-1.10085,"twenty":-37.438053,"median":-9.227851,"eighty":-3.551938,"marketCap":7606207.65},{"date":"2023-03-10","current":-1.198293,"twenty":-37.438053,"median":-9.227851,"eighty":-3.45974,"marketCap":8185550.86},{"date":"2023-03-17","current":-1.120516,"twenty":-37.438053,"median":-9.227851,"eighty":-2.755547,"marketCap":7980631.72},{"date":"2023-03-24","current":-0.916786,"twenty":-37.438053,"median":-9.227851,"eighty":-2.696359,"marketCap":6519731.67},{"date":"2023-03-31","current":-0.417647,"twenty":-37.438053,"median":-9.227851,"eighty":-2.624017,"marketCap":3018701.27},{"date":"2023-04-06","current":-0.132425,"twenty":-37.438053,"median":-9.227851,"eighty":-2.584558,"marketCap":960449.73},{"date":"2023-04-14","current":-0.500779,"twenty":-37.438053,"median":-9.227851,"eighty":-2.531947,"marketCap":3666478.25},{"date":"2023-04-21","current":-0.622397,"twenty":-37.438053,"median":-9.227851,"eighty":-2.499064,"marketCap":4520895.91},{"date":"2023-04-28","current":-0.579473,"twenty":-37.438053,"median":-9.227851,"eighty":-2.453029,"marketCap":4166925.01},{"date":"2023-05-05","current":-0.550857,"twenty":-37.438053,"median":-9.227851,"eighty":-2.433299,"marketCap":3966371.91},{"date":"2023-05-12","current":-0.558011,"twenty":-37.438053,"median":-9.227851,"eighty":-2.433299,"marketCap":4046484.45},{"date":"2023-05-19","current":-0.572319,"twenty":-37.438053,"median":-9.227851,"eighty":-2.400417,"marketCap":4145445.66},{"date":"2023-05-26","current":-0.58694,"twenty":-37.438053,"median":-9.227851,"eighty":-2.367534,"marketCap":4210059.56},{"date":"2023-06-02","current":-0.550709,"twenty":-37.438053,"median":-9.227851,"eighty":-2.367534,"marketCap":3999105.96},{"date":"2023-06-09","current":-0.514478,"twenty":-34.942175,"median":-9.227851,"eighty":-2.321499,"marketCap":3767591.98},{"date":"2023-06-16","current":-0.531091,"twenty":-33.278257,"median":-9.227851,"eighty":-2.30177,"marketCap":3748293.76},{"date":"2023-06-23","current":-0.458354,"twenty":-33.278257,"median":-9.227851,"eighty":-2.28204,"marketCap":3234938.84},{"date":"2023-06-30","current":-0.478478,"twenty":-30.295333,"median":-9.227851,"eighty":-2.043589,"marketCap":3376966.22},{"date":"2023-07-07","current":-0.436578,"twenty":-26.688751,"median":-9.227851,"eighty":-1.802136,"marketCap":3081249.21},{"date":"2023-07-14","current":-0.436972,"twenty":-26.688751,"median":-8.613576,"eighty":-1.651163,"marketCap":3084034.14},{"date":"2023-07-21","current":-0.43717,"twenty":-26.688751,"median":-8.613576,"eighty":-1.562418,"marketCap":3085429.18},{"date":"2023-07-28","current":-0.458608,"twenty":-26.688751,"median":-8.613576,"eighty":-1.560974,"marketCap":3236727.75},{"date":"2023-08-04","current":-0.483799,"twenty":-26.688751,"median":-8.613576,"eighty":-1.558522,"marketCap":3414522.56},{"date":"2023-08-11","current":-0.383836,"twenty":-26.688751,"median":-6.222948,"eighty":-1.516375,"marketCap":2709008.42},{"date":"2023-08-18","current":-0.372906,"twenty":-26.688751,"median":-5.926622,"eighty":-1.471776,"marketCap":2631871.39},{"date":"2023-08-25","current":-0.39406,"twenty":-26.688751,"median":-5.926622,"eighty":-1.471776,"marketCap":2781166.24},{"date":"2023-09-01","current":-0.447028,"twenty":-26.688751,"median":-5.926622,"eighty":-1.427176,"marketCap":3155002.59},{"date":"2023-09-08","current":-0.442472,"twenty":-19.813329,"median":-5.926622,"eighty":-1.427176,"marketCap":3122844.46},{"date":"2023-09-15","current":-0.187109,"twenty":-19.430851,"median":-5.926622,"eighty":-1.427176,"marketCap":1320569.3},{"date":"2023-09-22","current":-0.388305,"twenty":-19.430851,"median":-5.926622,"eighty":-1.427176,"marketCap":2475737.22},{"date":"2023-09-29","current":-0.315336,"twenty":-19.430851,"median":-5.926622,"eighty":-1.415486,"marketCap":2010507.36},{"date":"2023-10-06","current":-0.365327,"twenty":-19.430851,"median":-5.926622,"eighty":-1.395726,"marketCap":2329231.67},{"date":"2023-10-13","current":-0.367265,"twenty":-19.430851,"median":-5.926622,"eighty":-1.382577,"marketCap":2341589.46},{"date":"2023-10-20","current":-0.334674,"twenty":-19.430851,"median":-5.926622,"eighty":-1.368527,"marketCap":2133796.18},{"date":"2023-10-27","current":-0.290523,"twenty":-19.430851,"median":-5.926622,"eighty":-1.366813,"marketCap":1852300.65},{"date":"2023-11-03","current":-0.316281,"twenty":-19.430851,"median":-5.926622,"eighty":-1.360278,"marketCap":2016523.46},{"date":"2023-11-10","current":-0.325261,"twenty":-19.430851,"median":-5.390754,"eighty":-1.337978,"marketCap":2073784.82},{"date":"2023-11-17","current":-0.300361,"twenty":-19.430851,"median":-5.330934,"eighty":-1.337515,"marketCap":1915028.46},{"date":"2023-11-24","current":-0.302508,"twenty":-19.430851,"median":-5.327909,"eighty":-1.335149,"marketCap":1928712.73},{"date":"2023-12-01","current":-0.350938,"twenty":-19.430851,"median":-5.327909,"eighty":-1.296306,"marketCap":2237493.37},{"date":"2023-12-08","current":-0.980569,"twenty":-19.430851,"median":-5.327909,"eighty":-1.274244,"marketCap":6251864.25},{"date":"2023-12-15","current":-0.736628,"twenty":-19.430851,"median":-5.327909,"eighty":-1.271301,"marketCap":4696557.28},{"date":"2023-12-22","current":-0.812759,"twenty":-19.430851,"median":-5.327909,"eighty":-1.259672,"marketCap":5181946.56},{"date":"2023-12-29","current":-0.682126,"twenty":-19.430851,"median":-5.327909,"eighty":-1.237797,"marketCap":4349066.88},{"date":"2024-01-05","current":-0.630384,"twenty":-19.430851,"median":-5.327909,"eighty":-1.211461,"marketCap":4019166.25},{"date":"2024-01-12","current":-0.436686,"twenty":-19.430851,"median":-5.327909,"eighty":-1.179486,"marketCap":2784200.42},{"date":"2024-01-19","current":-0.561866,"twenty":-19.430851,"median":-5.327909,"eighty":-1.15795,"marketCap":3582314.16},{"date":"2024-01-26","current":-0.716167,"twenty":-19.430851,"median":-5.327909,"eighty":-1.132962,"marketCap":4566100.74},{"date":"2024-02-02","current":-0.652747,"twenty":-19.430851,"median":-5.327909,"eighty":-1.116775,"marketCap":5627224.65},{"date":"2024-02-09","current":-0.504935,"twenty":-19.430851,"median":-5.327909,"eighty":-1.1005,"marketCap":4352964.23},{"date":"2024-02-16","current":-0.519849,"twenty":-19.430851,"median":-5.327909,"eighty":-1.096168,"marketCap":4481532.37},{"date":"2024-02-23","current":-0.672729,"twenty":-18.473966,"median":-5.327909,"eighty":-1.087585,"marketCap":5799482.19},{"date":"2024-03-01","current":-0.54179,"twenty":-18.473966,"median":-5.327909,"eighty":-1.08191,"marketCap":4670679.77},{"date":"2024-03-08","current":-0.505134,"twenty":-18.473966,"median":-5.327909,"eighty":-1.079739,"marketCap":4354677.58},{"date":"2024-03-15","current":-0.435211,"twenty":-18.473966,"median":-5.327909,"eighty":-1.064778,"marketCap":3751886.19},{"date":"2024-03-22","current":-0.499967,"twenty":-18.473966,"median":-5.327909,"eighty":-1.046318,"marketCap":4044318},{"date":"2024-03-28","current":-0.471743,"twenty":-18.473966,"median":-5.327909,"eighty":-0.975962,"marketCap":3816009},{"date":"2024-04-05","current":-0.463679,"twenty":-18.473966,"median":-5.327909,"eighty":-0.890377,"marketCap":3750779},{"date":"2024-04-12","current":-0.516095,"twenty":-18.473966,"median":-5.327909,"eighty":-0.810049,"marketCap":4174780},{"date":"2024-04-19","current":-0.475009,"twenty":-18.473966,"median":-5.327909,"eighty":-0.7392,"marketCap":3842428},{"date":"2024-04-26","current":-0.483839,"twenty":-18.473966,"median":-5.327909,"eighty":-0.711567,"marketCap":3913856},{"date":"2024-05-03","current":-0.471784,"twenty":-18.473966,"median":-5.327909,"eighty":-0.652729,"marketCap":3816336},{"date":"2024-05-10","current":-0.604799,"twenty":-18.473966,"median":-5.327909,"eighty":-0.644215,"marketCap":4892320},{"date":"2024-05-17","current":-0.520127,"twenty":-18.473966,"median":-5.327909,"eighty":-0.61393,"marketCap":4207395},{"date":"2024-05-24","current":-0.453599,"twenty":-18.473966,"median":-5.327909,"eighty":-0.600881,"marketCap":3669240},{"date":"2024-05-31","current":-0.459647,"twenty":-18.473966,"median":-5.327909,"eighty":-0.594105,"marketCap":3718163},{"date":"2024-06-07","current":-0.420053,"twenty":-18.473966,"median":-5.109555,"eighty":-0.586092,"marketCap":3397879},{"date":"2024-06-14","current":-0.435455,"twenty":-18.473966,"median":-5.074202,"eighty":-0.577013,"marketCap":3522470},{"date":"2024-06-21","current":-0.612279,"twenty":-18.473966,"median":-5.074202,"eighty":-0.572319,"marketCap":4237588},{"date":"2024-06-28","current":-0.64098,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":4436225},{"date":"2024-07-05","current":-0.727082,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5032136},{"date":"2024-07-12","current":-0.770133,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5330091},{"date":"2024-07-15","current":-0.813184,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5628047},{"date":"2024-08-02","current":-0.717515,"twenty":-19.331844,"median":-5.074202,"eighty":-0.562464,"marketCap":4965924},{"date":"2024-08-09","current":-0.569229,"twenty":-19.331844,"median":-5.074202,"eighty":-0.562464,"marketCap":3939633},{"date":"2024-08-16","current":-0.545311,"twenty":-19.331844,"median":-5.074202,"eighty":-0.558549,"marketCap":3774102},{"date":"2024-08-23","current":-0.660114,"twenty":-19.331844,"median":-5.008674,"eighty":-0.558011,"marketCap":4568650},{"date":"2024-08-30","current":-0.631413,"twenty":-19.331844,"median":-4.791826,"eighty":-0.558011,"marketCap":4370013},{"date":"2024-09-06","current":-0.617063,"twenty":-19.331844,"median":-4.539624,"eighty":-0.558011,"marketCap":4270694},{"date":"2024-09-13","current":-0.631413,"twenty":-19.331844,"median":-4.09773,"eighty":-0.558011,"marketCap":4370013},{"date":"2024-09-20","current":-0.506022,"twenty":-19.331844,"median":-4.059359,"eighty":-0.552636,"marketCap":4270694},{"date":"2024-09-27","current":-0.595973,"twenty":-19.331844,"median":-4.059359,"eighty":-0.550947,"marketCap":5029855},{"date":"2024-10-04","current":-0.595973,"twenty":-19.331844,"median":-4.059359,"eighty":-0.550947,"marketCap":5029855},{"date":"2024-10-11","current":-0.653648,"twenty":-19.331844,"median":-4.04729,"eighty":-0.550947,"marketCap":5516615},{"date":"2024-10-18","current":-0.634423,"twenty":-19.331844,"median":-2.811447,"eighty":-0.550947,"marketCap":5354362},{"date":"2024-10-25","current":-0.74016,"twenty":-19.331844,"median":-2.696359,"eighty":-0.550947,"marketCap":6246755},{"date":"2024-10-31","current":-0.70171,"twenty":-19.331844,"median":-2.614152,"eighty":-0.550947,"marketCap":5922249},{"date":"2024-11-08","current":-0.672873,"twenty":-19.430851,"median":-2.531947,"eighty":-0.550857,"marketCap":5678869},{"date":"2024-11-15","current":-0.706517,"twenty":-19.430851,"median":-2.499064,"eighty":-0.550857,"marketCap":5962812},{"date":"2024-11-22","current":-0.644036,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5435488},{"date":"2024-11-29","current":-0.624811,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5273235},{"date":"2024-12-06","current":-0.639229,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5394925},{"date":"2024-12-13","current":-0.70171,"twenty":-19.430851,"median":-2.400417,"eighty":-0.550857,"marketCap":5922249},{"date":"2024-12-20","current":-0.571942,"twenty":-19.430851,"median":-2.367534,"eighty":-0.550857,"marketCap":4827038},{"date":"2024-12-27","current":-0.749773,"twenty":-19.430851,"median":-2.367534,"eighty":-0.550857,"marketCap":6327882},{"date":"2025-01-03","current":-0.696904,"twenty":-19.430851,"median":-2.30177,"eighty":-0.550857,"marketCap":5881685},{"date":"2025-01-10","current":-0.692098,"twenty":-19.430851,"median":-2.30177,"eighty":-0.550857,"marketCap":5841122},{"date":"2025-01-17","current":-0.730548,"twenty":-19.430851,"median":-2.153798,"eighty":-0.550857,"marketCap":6165629},{"date":"2025-01-24","current":-1.150202,"twenty":-19.430851,"median":-1.874119,"eighty":-0.550857,"marketCap":6043939},{"date":"2025-01-31","current":-1.042129,"twenty":-19.430851,"median":-1.662503,"eighty":-0.550857,"marketCap":5476052},{"date":"2025-02-07","current":-1.160721,"twenty":-19.430851,"median":-1.581046,"eighty":-0.550857,"marketCap":6099215},{"date":"2025-02-14","current":-1.13637,"twenty":-19.430851,"median":-1.560974,"eighty":-0.550857,"marketCap":5971260},{"date":"2025-02-21","current":-1.038967,"twenty":-19.430851,"median":-1.560974,"eighty":-0.550857,"marketCap":5459438},{"date":"2025-02-28","current":-0.990265,"twenty":-19.430851,"median":-1.541199,"eighty":-0.550857,"marketCap":5203526},{"date":"2025-03-07","current":-0.900979,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":4734356},{"date":"2025-03-14","current":-0.917213,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":4819660},{"date":"2025-03-21","current":-1.211596,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":6007699},{"date":"2025-03-28","current":-1.08733,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":5391525},{"date":"2025-04-04","current":-1.066619,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":5288829},{"date":"2025-04-11","current":-0.966947,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":4794606},{"date":"2025-04-17","current":-1.004486,"twenty":-19.430851,"median":-1.424416,"eighty":-0.550857,"marketCap":4980742},{"date":"2025-04-25","current":-1.014841,"twenty":-19.430851,"median":-1.40109,"eighty":-0.550857,"marketCap":5032090},{"date":"2025-05-02","current":-1.056263,"twenty":-19.430851,"median":-1.382577,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-05-09","current":-1.011735,"twenty":-19.430851,"median":-1.375382,"eighty":-0.550857,"marketCap":5016685},{"date":"2025-05-16","current":-1.004486,"twenty":-19.430851,"median":-1.366813,"eighty":-0.550857,"marketCap":4980742},{"date":"2025-05-23","current":-1.035552,"twenty":-19.430851,"median":-1.360278,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-05-30","current":-1.001379,"twenty":-19.430851,"median":-1.337978,"eighty":-0.550857,"marketCap":4965338},{"date":"2025-06-06","current":-0.973316,"twenty":-19.430851,"median":-1.337978,"eighty":-0.550857,"marketCap":4826185},{"date":"2025-06-13","current":-0.909542,"twenty":-19.430851,"median":-1.332642,"eighty":-0.550857,"marketCap":4396917},{"date":"2025-06-20","current":-0.913472,"twenty":-19.430851,"median":-1.295818,"eighty":-0.550857,"marketCap":4415915},{"date":"2025-06-27","current":-0.936415,"twenty":-19.430851,"median":-1.273609,"eighty":-0.550857,"marketCap":4526827},{"date":"2025-07-03","current":-1.168394,"twenty":-19.430851,"median":-1.261673,"eighty":-0.550857,"marketCap":5648264},{"date":"2025-07-11","current":-1.040933,"twenty":-19.430851,"median":-1.240431,"eighty":-0.550857,"marketCap":5032090},{"date":"2025-07-18","current":-1.072798,"twenty":-18.473966,"median":-1.211461,"eighty":-0.550857,"marketCap":5186133},{"date":"2025-07-25","current":-1.094042,"twenty":-18.243042,"median":-1.202815,"eighty":-0.550857,"marketCap":5288829},{"date":"2025-08-01","current":-1.062177,"twenty":-18.012117,"median":-1.178715,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-08-08","current":-1.08342,"twenty":-17.781192,"median":-1.163301,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-08-15","current":-1.08342,"twenty":-17.615217,"median":-1.153532,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-08-22","current":-1.062177,"twenty":-17.615217,"median":-1.142724,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-08-29","current":-1.08342,"twenty":-17.615217,"median":-1.133121,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-09-05","current":-1.083951,"twenty":-17.615217,"median":-1.119324,"eighty":-0.550857,"marketCap":5240049},{"date":"2025-09-12","current":-1.115286,"twenty":-17.615217,"median":-1.118135,"eighty":-0.550857,"marketCap":5391525},{"date":"2025-09-19","current":-1.348445,"twenty":-17.589237,"median":-1.118135,"eighty":-0.550857,"marketCap":5466441},{"date":"2025-09-26","current":-1.429352,"twenty":-17.319343,"median":-1.118135,"eighty":-0.550857,"marketCap":5794427},{"date":"2025-10-03","current":-1.375414,"twenty":-16.996048,"median":-1.118135,"eighty":-0.550857,"marketCap":5575769},{"date":"2025-10-10","current":-1.29626,"twenty":-16.765124,"median":-1.118135,"eighty":-0.550857,"marketCap":5254889},{"date":"2025-10-17","current":-1.277382,"twenty":-16.16472,"median":-1.118135,"eighty":-0.550857,"marketCap":5178359},{"date":"2025-10-24","current":-1.324577,"twenty":-16.16472,"median":-1.118135,"eighty":-0.550857,"marketCap":5369684},{"date":"2025-10-31","current":-1.222905,"twenty":-15.610501,"median":-1.118135,"eighty":-0.550857,"marketCap":4957515},{"date":"2025-11-07","current":-0.999602,"twenty":-14.779173,"median":-1.11003,"eighty":-0.550857,"marketCap":4052272},{"date":"2025-11-14","current":-0.466831,"twenty":-14.455878,"median":-1.100951,"eighty":-0.550765,"marketCap":1892481},{"date":"2025-11-21","current":-0.268071,"twenty":-14.224953,"median":-1.099975,"eighty":-0.546197,"marketCap":1086728},{"date":"2025-11-28","current":-0.24222,"twenty":-14.086399,"median":-1.095371,"eighty":-0.543703,"marketCap":981932},{"date":"2025-12-05","current":-0.673835,"twenty":-13.62455,"median":-1.094042,"eighty":-0.543703,"marketCap":2731651},{"date":"2025-12-12","current":-1.06106,"twenty":-13.393625,"median":-1.088758,"eighty":-0.543703,"marketCap":4301415},{"date":"2025-12-19","current":-0.965609,"twenty":-13.162701,"median":-1.087521,"eighty":-0.543703,"marketCap":3914467},{"date":"2025-12-26","current":-0.84722,"twenty":-13.162701,"median":-1.085641,"eighty":-0.543703,"marketCap":3434532},{"date":"2026-01-02","current":-0.669637,"twenty":-12.700852,"median":-1.08342,"eighty":-0.543703,"marketCap":2714630},{"date":"2026-01-09","current":-0.899015,"twenty":-12.146632,"median":-1.08342,"eighty":-0.543703,"marketCap":3644504},{"date":"2026-01-16","current":-0.973008,"twenty":-11.587771,"median":-1.080702,"eighty":-0.543703,"marketCap":3944463},{"date":"2026-01-23","current":-1.049901,"twenty":-11.587771,"median":-1.079739,"eighty":-0.543703,"marketCap":4049449},{"date":"2026-01-30","current":-0.851586,"twenty":-11.587771,"median":-1.073308,"eighty":-0.543703,"marketCap":3284553},{"date":"2026-02-06","current":-0.563836,"twenty":-8.613576,"median":-1.072243,"eighty":-0.543703,"marketCap":2174704},{"date":"2026-02-13","current":-0.423849,"twenty":-8.613576,"median":-1.066619,"eighty":-0.541026,"marketCap":1634777},{"date":"2026-02-20","current":-0.577021,"twenty":-8.613576,"median":-1.066037,"eighty":-0.537847,"marketCap":2225559},{"date":"2026-02-27","current":-0.53514,"twenty":-8.613576,"median":-1.062177,"eighty":-0.536549,"marketCap":2064026},{"date":"2026-03-06","current":-0.502566,"twenty":-8.613576,"median":-1.05906,"eighty":-0.536549,"marketCap":1938390},{"date":"2026-03-13","current":-0.385627,"twenty":-4.943147,"median":-1.056151,"eighty":-0.53281,"marketCap":1487355},{"date":"2026-03-20","current":-0.206114,"twenty":-4.77165,"median":-1.051024,"eighty":-0.530164,"marketCap":1368585},{"date":"2026-03-27","current":-0.231847,"twenty":-4.428656,"median":-1.04883,"eighty":-0.52897,"marketCap":1539450},{"date":"2026-04-02","current":-0.339748,"twenty":-3.99487,"median":-1.046113,"eighty":-0.523835,"marketCap":2255910},{"date":"2026-04-10","current":-0.377498,"twenty":-2.748971,"median":-1.042127,"eighty":-0.520127,"marketCap":2506567},{"date":"2026-04-17","current":-0.262518,"twenty":-2.696359,"median":-1.040933,"eighty":-0.5179,"marketCap":1743108},{"date":"2026-04-24","current":-0.257359,"twenty":-2.597711,"median":-1.035552,"eighty":-0.514478,"marketCap":1708852},{"date":"2026-05-01","current":-0.224108,"twenty":-2.531947,"median":-1.031531,"eighty":-0.511783,"marketCap":1488065},{"date":"2026-05-08","current":-0.86327,"twenty":-2.485911,"median":-1.024161,"eighty":-0.510296,"marketCap":5732064},{"date":"2026-05-15","current":-0.811243,"twenty":-2.433299,"median":-1.014273,"eighty":-0.510296,"marketCap":5386612},{"date":"2026-05-22","current":-0.377536,"twenty":-2.433299,"median":-1.008005,"eighty":-0.505681,"marketCap":2506821},{"date":"2026-05-29","current":-0.376002,"twenty":-2.400417,"median":-1.004486,"eighty":-0.504039,"marketCap":2496630},{"date":"2026-06-05","current":-0.446598,"twenty":-2.367534,"median":-0.999455,"eighty":-0.499967,"marketCap":2965386},{"date":"2026-06-12","current":-0.51259,"twenty":-2.367534,"median":-0.994596,"eighty":-0.498651,"marketCap":3403570},{"date":"2026-06-18","current":-0.404845,"twenty":-2.321499,"median":-0.991077,"eighty":-0.492739,"marketCap":3199763},{"date":"2026-06-26","current":-0.468013,"twenty":-2.30177,"median":-0.980602,"eighty":-0.49207,"marketCap":3699021},{"date":"2026-07-02","current":-0.432301,"twenty":-2.262311,"median":-0.977044,"eighty":-0.488105,"marketCap":3416767},{"date":"2026-07-10","current":-0.389071,"twenty":-1.976951,"median":-0.969308,"eighty":-0.483839,"marketCap":3075090},{"date":"2026-07-17","current":-0.374035,"twenty":-1.699795,"median":-0.957532,"eighty":-0.482232,"marketCap":2956246},{"date":"2026-07-24","current":-0.312009,"twenty":-1.620915,"median":-0.952708,"eighty":-0.478963,"marketCap":2466014},{"date":"2026-07-31","current":-0.30449,"twenty":-1.560974,"median":-0.941592,"eighty":-0.477791,"marketCap":2406592},{"date":"2026-08-07","current":-0.328925,"twenty":-1.560974,"median":-0.934845,"eighty":-0.474646,"marketCap":2599714},{"date":"2026-08-14","current":-0.347721,"twenty":-1.557909,"median":-0.925121,"eighty":-0.472163,"marketCap":2748269},{"date":"2026-08-21","current":-0.325166,"twenty":-1.516375,"median":-0.919213,"eighty":-0.470511,"marketCap":2570003},{"date":"2026-08-28","current":-0.340202,"twenty":-1.471776,"median":-0.912941,"eighty":-0.467711,"marketCap":2688847},{"date":"2026-09-04","current":-0.319527,"twenty":-1.471776,"median":-0.899997,"eighty":-0.463679,"marketCap":2525436},{"date":"2026-09-11","current":-0.194497,"twenty":-1.471776,"median":-0.886355,"eighty":-0.463679,"marketCap":1458216},{"date":"2026-09-18","current":-0.385328,"twenty":-1.427176,"median":-0.859224,"eighty":-0.459647,"marketCap":2888945},{"date":"2026-09-25","current":-0.363906,"twenty":-1.427176,"median":-0.845554,"eighty":-0.458608,"marketCap":2728336},{"date":"2026-10-02","current":-0.321466,"twenty":-1.427176,"median":-0.826673,"eighty":-0.455615,"marketCap":2410147},{"date":"2026-10-06","current":-0.336825,"twenty":-1.427176,"median":-0.823689,"eighty":-0.455615,"marketCap":2525298}],"updateTime":1791445937258},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CMND\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634211921","title":"Clearmind doses 2 more patients in CMND-100 alcohol use disorder trial cohort 4","url":"https://stock-news.laohu8.com/highlight/detail?id=2634211921","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634211921?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:41","pubTimestamp":1778589679,"startTime":"0","endTime":"0","summary":"Clearmind Medicine dosed two more patients in fourth cohort of its FDA-cleared Phase I/IIa trial of CMND-100 for moderate to severe alcohol use disorder, lifting total treated to 20.Results have not been presented; trial remains ongoing, with safety, tolerability, drug exposure, and early signs of benefit still being evaluated.So far, study has shown encouraging safety and tolerability, with no serious adverse events reported in first three cohorts.Fourth cohort moved to a higher dose following a positive independent safety review, supporting continued dose escalation.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL9t8GL1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","CMND","SG9999014005.SGD","NDAQ","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4007","BK4585","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","SG9999014039.USD","BK4588","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634607211","title":"Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants NOW Treated in Ongoing Phase I/Iia Trial of Cmnd-100 for Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2634607211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634607211?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:41","pubTimestamp":1778589660,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUABQLD0P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634211781","title":"Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2634211781","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634211781?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:41","pubTimestamp":1778589660,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, May  12, 2026  (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the \"Company\"), a clinical-stage biotech company focused on the discovery and development o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3292863/0/en/Clearmind-Medicine-Reaches-Important-Clinical-Milestone-20-Participants-Now-Treated-in-Ongoing-Phase-I-IIa-Trial-of-CMND-100-for-Alcohol-Use-Disorder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634378286","title":"Clearmind Medicine to host “Inside MEAI” webinar on CMND-100 trial data","url":"https://stock-news.laohu8.com/highlight/detail?id=2634378286","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634378286?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:55","pubTimestamp":1778500516,"startTime":"0","endTime":"0","summary":"Clearmind Medicine will host live webinar “Inside MEAI: New Insights from CMND-100 Psychedelic Clinical Trial” on June 10, 2026, 4:00 PM–5:00 PM IDT.Session set to review latest clinical data from ongoing FDA-approved Phase I/IIa multi-center trial of CMND-100, a non-hallucinogenic MEAI-based oral candidate for Alcohol Use Disorder.Webinar scheduled to include presentations from trial investigators at Yale School of Medicine, Johns Hopkins Medicine, followed by live Q&A.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLc1HtpQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014005.SGD","IE00BN0W2W23.USD","BK4588","CMND","BK4112","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","SG9999014039.USD","BK4585","LU2095319765.USD","SG9999014013.SGD","BK4007","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634323286","title":"Clearmind Medicine Announces “Inside Meai” Webinar Featuring New Insights From Cmnd-100 Psychedelic Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2634323286","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634323286?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:55","pubTimestamp":1778500500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA4JXRCF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633943966","title":"BRIEF-Clearmind Medicine Announces Filing Of European Patent Application For Novel Psychedelic Compounds For The Treatment Of Ptsd","url":"https://stock-news.laohu8.com/highlight/detail?id=2633943966","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633943966?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:53","pubTimestamp":1777985586,"startTime":"0","endTime":"0","summary":"BRIEF-Clearmind Medicine Announces Filing Of European Patent Application For Novel Psychedelic Compounds For The Treatment Of PtsdMay 5 (Reuters) - Clearmind Medicine Inc CMND.O:CLEARMIND MEDICINE ANN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nFWN41I167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633943647","title":"Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of Ptsd","url":"https://stock-news.laohu8.com/highlight/detail?id=2633943647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633943647?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:50","pubTimestamp":1777985451,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nFWN41I167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632610196","title":"Clearmind names Hila Kiron-Revach board chair after Amitay Weiss steps down","url":"https://stock-news.laohu8.com/highlight/detail?id=2632610196","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632610196?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:02","pubTimestamp":1777582943,"startTime":"0","endTime":"0","summary":"Clearmind Medicine said board chair Amitay Weiss resigned effective immediately on April 26, 2026.Directors appointed Asaf Itzhaik to compensation committee plus nominating and corporate governance committee.Audit committee chair role shifted to Itzhaik, with Kiron-Revach plus Yehonatan Shachar also serving.Board classified Kiron-Revach, Shachar plus Itzhaik as independent directors under Nasdaq listing standards.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the informat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL7vwrM7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630128395","title":"Clearmind evaluates MEAI for FDA breakthrough therapy designation in alcohol use disorder trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2630128395","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630128395?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:43","pubTimestamp":1777290207,"startTime":"0","endTime":"0","summary":"Clearmind Medicine began evaluating lead candidate CMND-100  for potential FDA Breakthrough Therapy Designation for Alcohol Use Disorder.Positive clinical results have already been presented from its ongoing FDA-approved Phase I/IIa trial, supporting eligibility assessment.Program targets a non-hallucinogenic treatment approach, positioning CMND-100 as a potential new option in a market with limited effective therapies.No Breakthrough Therapy Designation request has been submitted for MEAI, with no FDA designation granted as of April 27, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL3LhkPr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","CMND","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014013.SGD","LU0314104364.USD","BK4007","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","BK4588","SG9999014005.SGD","LU2210150020.SGD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395135","title":"Clearmind Medicine Inc - Has Not Submitted or Received FDA Breakthrough Therapy Designation for Meai","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395135","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630395135?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:41","pubTimestamp":1777290060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA1WN8P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629779252","title":"Clearmind Medicine issues $2.7 million convertible notes at 10% discount","url":"https://stock-news.laohu8.com/highlight/detail?id=2629779252","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629779252?lang=en_us&edition=fundamental","pubTime":"2026-04-21 05:18","pubTimestamp":1776719923,"startTime":"0","endTime":"0","summary":"Clearmind Medicine entered agreement on April 20, 2026 to sell convertible promissory notes with aggregate principal amount of USD 2.7 million.Cash purchase price set at 90% of principal, or USD 2.43 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 20, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL7ggxL7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629756227","title":"Clearmind welcomes Trump executive order speeding FDA review of breakthrough psychedelic therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2629756227","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629756227?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:03","pubTimestamp":1776715424,"startTime":"0","endTime":"0","summary":"Clearmind welcomed President Donald Trump’s April 18, 2026 executive order directing FDA to prioritize reviews for certain breakthrough-designated psychedelic therapies.Executive order also expands patient access pathways, which Clearmind framed as a catalyst for veteran mental health care.Clearmind highlighted February 2026 bipartisan House bill H.R. 7091 as a milestone that explicitly named its MEAI compound for potential VA-supported trials.Company said it is advancing FDA-authorized Phase I/IIa trials of lead candidate CMND-100 for alcohol use disorder at Yale School of Medicine and Johns Hopkins University.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDLTf5rZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","IE00BN0W2T93.GBP","SG9999014013.SGD","IE00B64PRP62.GBP","NDAQ","BK4007","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","BK4588","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4585","SG9999014021.USD","LU2210150020.SGD","LU2095319765.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628265087","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:34 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2628265087","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628265087?lang=en_us&edition=fundamental","pubTime":"2026-04-20 21:34","pubTimestamp":1776692072,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:34 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nAQN2LVC04:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628422427","title":"Clearmind says CMND-100 meets primary safety endpoint in AUD Phase I/IIa trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2628422427","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628422427?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:15","pubTimestamp":1776683722,"startTime":"0","endTime":"0","summary":"Clearmind Medicine reported positive top-line safety results from its FDA-approved Phase I/IIa trial of CMND-100 for Alcohol Use Disorder on April 20, 2026.Data from third cohort showed drug candidate was well tolerated at highest dose tested so far, with no serious adverse events reported.Study met its primary endpoint on safety and tolerability, supporting continued development of CMND-100 as a potential non-hallucinogenic oral treatment option for Alcohol Use Disorder.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL6T4625:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","CMND","SG9999014039.USD","BK4112","IE00BN0W2T93.GBP","BK4588","IE00B3QW5Z07.USD","NDAQ","IE00BN0W2W23.USD","LU2210150020.SGD","SG9999014005.SGD","IE00BGHQF748.EUR","BK4007","IE00B64PRP62.GBP","LU0314104364.USD","SG9999014013.SGD","SG9999014021.USD","LU2095319765.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628219742","title":"Clearmind Medicine Inc - Cmnd-100 Shows High Safety Profile at Highest Dosage With No Serious Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2628219742","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628219742?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:15","pubTimestamp":1776683703,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nFWN4130GP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628427957","title":"Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2628427957","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628427957?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:15","pubTimestamp":1776683700,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, April  20, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the \"Company\"), a clinical-stage biotech company focused on the discovery and development ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/20/3276876/0/en/Clearmind-Medicine-Announced-Positive-Top-Line-Safety-Results-CMND-100-Proprietary-Psychedelic-Treatment-Meets-Primary-Endpoint-in-AUD-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627212996","title":"Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627212996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627212996?lang=en_us&edition=fundamental","pubTime":"2026-04-16 23:27","pubTimestamp":1776353261,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a primary endpoint achievement, a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-clearminds-cmnd-100-meets-primary-endpoint-in-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-clearminds-cmnd-100-meets-primary-endpoint-in-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627721292","title":"Clearmind announces DSMB recommendation to continue CMND-100 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627721292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627721292?lang=en_us&edition=fundamental","pubTime":"2026-04-16 23:26","pubTimestamp":1776353212,"startTime":"0","endTime":"0","summary":"Clearmind Medicine (CMND) announced Wednesday that its independent Data and Safety Monitoring Board has completed its review and issued a positive ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearmind-announces-dsmb-recommendation-to-continue-cmnd-100-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearmind-announces-dsmb-recommendation-to-continue-cmnd-100-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627879032","title":"Clearmind advances CMND-100 alcohol use disorder trial, raises dose to 160 mg","url":"https://stock-news.laohu8.com/highlight/detail?id=2627879032","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627879032?lang=en_us&edition=fundamental","pubTime":"2026-04-15 21:16","pubTimestamp":1776259005,"startTime":"0","endTime":"0","summary":"Clearmind received a positive recommendation from an independent Data and Safety Monitoring Board to continue its FDA-approved Phase I/IIa trial of CMND-100 in patients with moderate to severe Alcohol Use Disorder.Top-line safety results have already been presented internally to the board, showing CMND-100 was well tolerated with no serious adverse events reported.Clearmind will advance to fourth cohort, raising tested dose to 160 mg.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 15, 2026, and is solely respons","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL7fBpnc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627579289","title":"Clearmind Medicine Inc - Cmnd-100 Well Tolerated With No Serious Adverse Events in Third Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2627579289","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627579289?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:30","pubTimestamp":1776252600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUA9DPH8H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":129,"code":"91000000","status":"200"}]}}